Citadel Advisors’s Sonoma Pharmaceuticals SNOA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,758
| Closed | -$41.4K | – | 6635 |
|
|
2024
Q2 | $41.4K | Buy |
+9,758
| New | +$41.4K | ﹤0.01% | 5234 |
|
|
2024
Q1 | – | Sell |
-5,839
| Closed | -$21.1K | – | 6775 |
|
|
2023
Q4 | $21.1K | Buy |
+5,839
| New | +$21.1K | ﹤0.01% | 5367 |
|
|
2022
Q4 | – | Sell |
-918
| Closed | -$39K | – | 6661 |
|
|
2022
Q3 | $39K | Sell |
918
-366
| -29% | -$15.5K | ﹤0.01% | 5391 |
|
|
2022
Q2 | $76K | Buy |
+1,284
| New | +$76K | ﹤0.01% | 5387 |
|
|
2019
Q2 | – | Sell |
-250
| Closed | -$42K | – | 5065 |
|
|
2019
Q1 | $42K | Buy |
+250
| New | +$42K | ﹤0.01% | 4274 |
|
|
2018
Q4 | – | Sell |
-60
| Closed | -$16K | – | 4905 |
|
|
2018
Q3 | $16K | Sell |
60
-19
| -24% | -$5.07K | ﹤0.01% | 4169 |
|
|
2018
Q2 | $35K | Buy |
+79
| New | +$35K | ﹤0.01% | 3959 |
|
|
2016
Q2 | – | Sell |
-24
| Closed | -$20K | – | 3847 |
|
|
2016
Q1 | $20K | Sell |
24
-7
| -23% | -$5.83K | ﹤0.01% | 3140 |
|
|
2015
Q4 | $32K | Sell |
31
-25
| -45% | -$25.8K | ﹤0.01% | 3526 |
|
|
2015
Q3 | $65K | Buy |
56
+43
| +331% | +$49.9K | ﹤0.01% | 3487 |
|
|
2015
Q2 | $16K | Sell |
13
-13
| -50% | -$16K | ﹤0.01% | 3638 |
|
|
2015
Q1 | $20K | Buy |
+26
| New | +$20K | ﹤0.01% | 3539 |
|